CoRegen
Business Services · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
801 Travis St, Houston, Texas, 77002, Un...Website
www.coregen.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About CoRegen
CoreGen Diagnostics is a biotechnology and precision medicine company that develops molecular diagnostic tests to help guide treatment decisions in oncology (cancer care). Their tests analyze genetic information from tumors to help doctors choose the most effective therapies for individual patients.Explore more
CoRegen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CoRegen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once CoRegen has new funding data
CoRegen, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when CoRegen launches new products
Check out if CoRegen is spiking on competitors!
Check if CoRegen has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at CoRegen
Earning: See what the market has to say on CoRegen recently announced quarterly report
Click to see if CoRegen had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at CoRegen
Find 2 more new buyers
Company Profile Activity
Activity Insights
CoRegen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CoRegen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CoRegen.
CoRegen financials insights
Gather financial insights about CoRegen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$93M
2026
Private Equity
$13.5M
CoRegen Tech Stack
A closer look at the technologies used by CoRegen
See more technologies
CoRegen News & Media
CoRegen, Inc. Strengthens Leadership Team with the Appointments of Sonja Nelson as Chief Financial Officer and Peter Gelinas as Chief Technical Officer
HOUSTON, Sept. 10, 2025 (GLOBE NEWSWIRE) -- CoRegen, Inc., a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of cancer, today announced the appointments of Sonja Nelson as Chief Financial Officer (CFO) and Peter Gelinas as Chief Technical Officer (CTO). Together, these appointments will further the company’s mission of pioneering next-generation treatments designed to eliminate cancer as we know it and redefine what’s possible in modCoRegen, Inc. Appoints Biotech Veteran Sonal Gupta, M.D., Ph.D., as Chief Medical Officer
HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- CoRegen, a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of cancer, today announced the appointment of industry veteran Sonal Gupta, M.D., Ph.D., as Chief Medical Officer (CMO) to advance the company’s strategy of altering the steroid receptor coactivator (SRC-3) gene to eradicate solid tumors.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CoRegen
Sign Up For FreeTo access detailed company insights
CoreGen Diagnostics is a biotechnology and precision medicine company that develops molecular diagnostic tests to help guide treatment decisions in oncology (cancer care). Their tests analyze genetic information from tumors to help doctors choose the most effective therapies for individual patients.... Read More
